Which country will have the largest Sciatica Market Size?

1. Which country will have the largest Sciatica Market Size? telegra.ph/Which-country-will-have-the-largest-Sciatica-Market-Size-02-23 February 23, 2021 Sciatica market The Sciatica treatment market mainly relies on nonpharmacologic interventions, such as physical therapy or behavioral therapy. In case these interventions do not prove to be fruitful then patients opt for pharmacological therapies. The treatment options include use of over-the-counter drugs only, such as NSAIDs, muscle relaxants, pain relievers, antidepressants, calcium channel α2-δ ligands, epidural steroids, opioids, and topical pain medications whose prolonged practice is also not beneficial for the patients. There is a need for developing specific targeted therapies/interventions to treat sciatica from the roots. Biomarkers are considered to be one of the most essential parameters in diagnosing any condition. By having an idea of biomarker it is easy to devise the drugs according to the pathophysiology of the disease. In case of Sciatica, there are no profound specific biomarkers available for the diagnosis. This scenario is difficult for the researchers or pathologists to define that the patient has sciatica. Therefore, there is an urgent need for new and efficient biomarkers that are specific to the target and thereby ease the diagnosis. Sciatica Market Companies like- 1/2

2. Scilex Holding, Seikagaku Corporation and others are coming up with novel therapeutic approaches that can entirely change the treatment landscape of Sciatica. If launched these emerging potential candidates could pose an effect on the current Sciatica pharmaceuticals giants, by means their expected potential to transform the standard of care for Sciatica patients 2/2